Figure 发布 Helix 02 模型，人形机器人全身自 主控制实现突破 机器人行业跟踪报告 | [姓名table_Authors] | 电话 | 邮箱 | 登记编号 | | --- | --- | --- | --- | | 肖群稀(分析师) | 0755-23976830 | xiaoqunxi@gtht.com | S0880522120001 | | 毛冠锦(分析师) | 021-23183821 | maoguanjin@gtht.com | S0880525040081 | 本报告导读： Figure Helix 02 发布，突破人形机器人全身自主控制核心技术。机器人可完成多场 景连贯精细作业，具备动态误差修复能力，为人形机器人商业化落地打开全新空间。 投资要点： [Table_Report] 相关报告 机器人《Optimus 预计 27 年 toC 销售，宇树 25 年出货 5500 台机器人》2026.01.24 机器人《1X Technologies 发布"世界模型"， Skild AI 获 14 亿美元融资》2026.01.19 机器人《CES 2026：定义 AI 物理边界，加速具 ...

证券日报网讯1月29日，汉威科技（300007）发布公告称，公司预计2025年度归属于上市公司股东的净 利润为12，500万元至17，500万元，比上年同期增长63.01%至128.22%。 ...

智通财经APP讯，汉威科技(300007.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净利润 1.25亿元至1.75亿元，同比增长63.01%至128.22%;扣除非经常性损益后的净利润4000万元至6000万元。 ...

| | | | 胡中原在管基金2025年收益率 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 基金代码 | 基金名称 | 章令荣型 | 规模(亿元) | 任职时间 | 任职天数 | 任职回报 | 2025年收益率 | | 020521.OF | 华商安恒债券A | 债券型-混合二级 | 104.67 | 2024-05-24 ~ 至今 | 1年又247天 | 16.78% | 7.58% | | 003598.OF | 华商润丰灵活配置混合A | 混合型-灵活 | 66.35 | 2019-03-19 ~ 至今 | 6年又315天 | 389.99% | 85.02% | | 007509.OF | 华商润丰灵活配置混合C | 混合型-灵活 | 63.17 | 2019-06-19 ~ 至今 | 6年又223天 | 386.50% | 84.87% | | 004206.OF | 华商元亨混合A | 混合型-灵活 | 29.32 | 2019-05-10 ~ 至今 | 6年又263天 | 358.61% | 88.24% | | 0 ...

证券代码：300007 证券简称：汉威科技 公告编号：2026-010 汉威科技集团股份有限公司 2025 年度，公司业绩变动主要原因如下： 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况：预计净利润为正值且属于同向上升 50%以上情形 单位：万元 | 项 目 | | 本报告期 | | | 上年同期 | | --- | --- | --- | --- | --- | --- | | 归属于上市公司 | | 12,500 | ～ | 17,500 | 7,668.03 | | 股东的净利润 | 比上年同期增长 | 63.01% | ～ | 128.22% | | | 扣除非经常性损 | | 4,000 | ～ | 6,000 | 563.33 | | 益后的净利润 | 比上年同期增长 | 610.06% | ～ | 965.10% | | 二、与会计师事务所沟通情况 本次业绩预告未经会计师事务所审计。公司已就本次业 ...

证券代码：300007 证券简称：汉威科技 公告编号：2026-009 董 事 会 2026 年 1 月 28 日 汉威科技集团股份有限公司（以下简称"公司"）于 2026 年 1 月 16 日召开 了第六届董事会第二十八次会议，审议通过了《关于公司董事会换届选举暨提名 第七届董事会独立董事候选人的议案》，提名刘之斐先生为第七届董事会独立董 事候选人，任期自 2026 年第一次临时股东会审议通过之日起三年。 截至公司 2026 年第一次临时股东会通知发出之日，刘之斐先生尚未取得独 立董事资格证书，根据深圳证券交易所的有关规定，刘之斐先生已书面承诺参加 最近一期独立董事资格培训并取得深圳证券交易所认可的独立董事资格证书。 近日，公司董事会收到独立董事候选人刘之斐先生的通知，其已按照相关规 定参加了深圳证券交易所举办的上市公司独立董事任前培训(线上)，并取得了由 深圳证券交易所创业企业培训中心颁发的《上市公司独立董事培训证明》。 特此公告。 汉威科技集团股份有限公司 汉威科技集团股份有限公司 关于独立董事候选人取得独立董事资格证书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误 ...

Group 1 - Tianqi Co., Ltd. has entered the brain-computer interface (BCI) sector by investing in Suzhou Huahui Chip, focusing on high-density flexible neural electrode technology, achieving animal testing stages, and becoming a key player in domestic BCI hardware localization. The developed flexible neural electrode has 1024 channels, with signal acquisition precision and anti-interference capabilities at an internationally advanced level. The company has also completed biocompatibility surface modification technology to reduce inflammation after electrode implantation, with core patents authorized by the National Intellectual Property Administration [1][2][3] - Innovation Medical, through its subsidiary Boling Brain Machine, is one of the first companies in China to commercialize BCI rehabilitation products. The core product, Cyberlink AC5, was officially launched in October 2025, generating sales revenue of 114,000 yuan in 2025. Another product, Cyberlink AM5, has completed multi-center clinical trials and is progressing through the approval process. The company plans to establish five additional clinical cooperation centers to accelerate the application of BCI technology in treating neurological diseases [4][5][6] - iFlytek is a leading company in the non-invasive BCI field, leveraging its artificial intelligence technology to develop BCI collaborative technology. The company has established long-term partnerships with universities for research and development. Its non-invasive BCI system has been piloted in 120 schools nationwide, improving student attention by 30%. In the medical field, a collaboration with Beijing Tiantan Hospital has achieved a 92% accuracy rate in identifying abnormal brain signals for epilepsy [7][8][9] Group 2 - Jiahe Intelligent focuses on the research and mass production of BCI hardware, particularly EEG acquisition devices and core components, serving both consumer and medical-grade markets. The company has achieved large-scale production of EEG acquisition headphones with a signal recognition accuracy of 92%, primarily used in sleep monitoring and attention training. It plans to expand into overseas BCI hardware markets by 2026 [10][11][12] - Tom Cat is the first company in China to apply BCI technology in consumer scenarios, focusing on interactive games and rehabilitation training products. The company launched a mind-controlled game product in 2025, which quickly gained over 500,000 users. It also collaborates with rehabilitation institutions to develop BCI rehabilitation training systems, showing a 35% average improvement in patient motor function scores [13][14][15] - Hanwei Technology, through its subsidiary Weisheng Technology, is a leading company in the EEG sensor field, with an annual shipment of over 2 million units. The company has developed an epilepsy early warning system with an 88% accuracy rate in clinical tests. It also focuses on flexible pressure sensors for invasive BCI electrodes, addressing industry pain points [16][17][18] Group 3 - StarNet Ruijie leverages its network communication technology to develop low-power, high-stability EEG signal transmission systems and data encryption modules, becoming a core supplier for BCI data links. The developed transmission system supports real-time transmission of 1024-channel EEG signals with a latency of less than 10ms and a stability of 99.9% [19][20][21] - Yijiahe focuses on the integration of BCI and embodied intelligent robots, exploring applications in smart healthcare. The company has signed a strategic cooperation agreement to develop real-time emotional companionship and brain-controlled robots, enhancing the emotional care capabilities of robots [22][23][24] - Lihua Technology is focused on incubating and investing in the BCI sector, successfully incubating three high-tech companies in the field. The company collaborates with the Shenzhen Institute of Advanced Technology to provide comprehensive services for incubated companies, addressing development pain points [25][26][27] Group 4 - Sanbo Neurosurgery is a leading private hospital in the neurosurgery field, focusing on the clinical application and research of BCI. The company has successfully conducted an interventional BCI surgery, accumulating valuable experience for clinical applications. It is also recruiting participants for ongoing clinical trials [28][29][30] - Shiyun Circuit is a core enterprise in the PCB field, providing customized PCB products for BCI devices. The company focuses on high-density, flexible PCB designs, achieving low signal loss rates below 2% [31][32][33] - Meihua Medical is a leading supplier of core components for BCI, having entered the core supply chain for invasive BCI products. The company has developed components that have passed biocompatibility tests, ensuring long-term stability and safety for implanted devices [34][35][36]

人形机器人概念盘初走强，百达精工、天奇股份双双涨停，中控技术涨超10%，兆丰股份、鹿山新材、 汉威科技、绿的谐波、福达股份等跟涨。 人形机器人概念盘初走强，百达精工、天奇股份双双涨停，中控技术涨超10%，兆丰股份、鹿山新材、 汉威科技、绿的谐波、福达股份等跟涨。 ...

Investment Rating - The industry rating is "Outperform the Market," indicating that the overall return of the industry is expected to exceed the market benchmark index by more than 5% over the next 6 months [14]. Core Insights - A breakthrough in Alzheimer's treatment was observed when a focused ultrasound surgery unexpectedly improved the cognitive function of a patient, challenging the traditional belief that Alzheimer's is irreversible. This condition affects nearly 17 million patients in China, leading to significant caregiving burdens [4][5]. - The research team led by Professor Sun Bomin is exploring a new approach using high-energy ultrasound to directly stimulate brain neural circuits, with initial clinical trials showing an average improvement rate of about 50% among seven moderate to severe patients [5]. - The global brain-computer interface (BCI) market is projected to grow rapidly, with an estimated size of approximately $2.62 billion in 2024, reaching $2.94 billion in 2025, and potentially growing to $12.4 billion by 2034, reflecting a compound annual growth rate of 17.35% over the next decade [6]. Summary by Sections Industry Overview - The report highlights the significant unmet medical need in Alzheimer's treatment and the potential for innovative therapies to emerge from recent clinical findings [4][5]. Market Potential - The brain-computer interface market is expected to see substantial growth, with specific projections for both global and Chinese markets, indicating a strategic focus on high-tech industries as outlined in national economic plans [6]. Investment Recommendations - The report suggests monitoring companies such as Yanshan Technology, Hanwei Technology, Sanbo Brain Science, and others, which are positioned to benefit from advancements in the BCI and related technologies [6].

Investment Rating - The report assigns an "Accumulate" rating for the robotics industry [4]. Core Insights - The report highlights the deepening strategies of overseas giants, with OpenAI entering the robotics field and the acceleration of embodied intelligence in Europe. In China, new products and operational scenarios are flourishing, with breakthroughs in both production scale and data elements. The investment and financing market is robust, leading to an expansion of the robotics supply chain and production capacity [2][3]. Summary by Sections Industry News and Company Dynamics - Optimus is already operational in factories and is expected to begin consumer sales by the end of 2027. CEO Elon Musk confirmed this timeline at the World Economic Forum in Davos, stating that several units are currently performing simple tasks and will be ready for more complex operations soon [6][7]. - Yushutech announced that it exceeded 5,500 units in actual sales of humanoid robots for 2025, with over 6,500 units produced. The company clarified that this figure refers to actual sales delivered to end customers [7]. - Shanghai Jiao Tong University and Jieke Robotics have established a joint research center focused on general intelligent robots, aiming for breakthroughs in core technologies and industrial applications [7]. Investment and Financing Dynamics - The financing demand in the robotics sector is increasing, with Skild AI raising approximately $1.4 billion in funding led by SoftBank and NVIDIA, focusing on developing a general robotic "brain" [9]. - Zhejiang Human Robot Innovation Center completed a Pre-A round financing of 450 million yuan, with a strong lineup of investors, aimed at advancing core technologies and scaling production [9]. - Huari Technology plans to go public in Hong Kong, focusing on machine vision and autonomous mobile robots [9]. Investment Recommendations - The report recommends focusing on both complete robotics manufacturers and core component suppliers. Key recommendations include: 1. Actuators and motors: Recommended companies include Zhaowei Electromechanical, with related companies being Mingzhi Electric and Jiechang Drive. 2. Reducers: Related companies include Ruidi Zhichu and Haoneng Co. 3. Screw components: Recommended company is Hengli Hydraulic, with related companies being Zhejiang Rongtai and Best. 4. Screw equipment: Recommended company is Qin Chuan Machine Tool, with related companies being Rifa Precision and Huachen Equipment. 5. Bearings: Recommended company is Longxi Co. 6. Sensors: Recommended companies include Donghua Testing and Anpeilong, with related companies being Lingyun Co. 7. Complete machines: Related companies include Ubtech and Yijiahe [10][12].